Live ClinicalTrials.gov data · Updated daily

Drug clinical trial pipelines

Visual phase 2–4 trial timelines for 52 drugs across 13 therapeutic classes. Every page is built from live ClinicalTrials.gov data and links into the free comparison tool. Put any drug head-to-head against up to four competitors and export the chart.

Open the comparison tool

Contents

TABLE OF CONTENTS

Head-to-head comparisons

Popular matchups

Semaglutide vs tirzepatide
Two leading GLP-1 therapies for obesity and type 2 diabetes
Cagrilintide vs tirzepatide
A GLP-1/amylin combination against a GLP-1/GIP dual agonist
Orforglipron vs semaglutide
An oral GLP-1 candidate against an injectable GLP-1 standard
Retatrutide vs tirzepatide
A triple agonist against a dual agonist in metabolic disease
Donanemab vs lecanemab
Two anti-amyloid antibodies for early Alzheimer's disease
Olezarsen vs pelacarsen
Two RNA-targeted therapies for lipid and Lp(a) lowering
Adagrasib vs sotorasib
Two KRAS G12C inhibitors in solid tumours
Nivolumab vs pembrolizumab
Two PD-1 checkpoint inhibitors in oncology
Sacituzumab govitecan vs trastuzumab deruxtecan
Two antibody-drug conjugates in solid tumours
Risankizumab vs upadacitinib
Two therapies for immune-mediated inflammatory disease

GLP-1 & incretin therapies

Metabolic

Cardiometabolic & renal

Metabolic

MASH / liver disease

Metabolic

Lipid & Lp(a) therapies

Cardiovascular

Cardiomyopathy & ATTR amyloidosis

Cardiovascular

Immuno-oncology checkpoint inhibitors

Oncology

Antibody-drug conjugates

Oncology

KRAS inhibitors

Oncology

Targeted & bispecific oncology

Oncology

Immunology & inflammation

Immunology

Neuroscience

Neuroscience

Women's health

Women's health

Respiratory

Respiratory

Join the waitlist

Be the first to access ComplyRx

We'll let you know as soon as your spot opens to use ComplyRx.

By joining, you agree to our Privacy Policy.